BIOPHARMA PROCESS SYSTEMS LIMITED

Active United Kingdom

Research and experimental development on biotechnology

66 employees website.com
Life sciences and medical technology Research and experimental development on biotechnologyOther professional, scientific and technical activities n.e.c.
B

BIOPHARMA PROCESS SYSTEMS LIMITED

Research and experimental development on biotechnology

Founded 23 Jan 1989 Active United Kingdom 66 employees website.com
Life sciences and medical technology Research and experimental development on biotechnologyOther professional, scientific and technical activities n.e.c.
Accounts Submitted 17 Jul 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 29 Mar 2026 Next due 31 Mar 2027 11 months remaining
Net assets £9M £142K 2024 year on year
Total assets £14M £2M 2024 year on year
Total Liabilities £4M £2M 2024 year on year
Charges 6
5 outstanding 1 satisfied

Contact & Details

Contact

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for BIOPHARMA PROCESS SYSTEMS LIMITED (02337313), an active life sciences and medical technology company based in United Kingdom. Incorporated 23 Jan 1989. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

£4.23M

Decreased by £888.49k (-17%)

Net Assets

£9.39M

Increased by £141.71k (+2%)

Total Liabilities

£4.39M

Increased by £1.53M (+54%)

Turnover

£10.09M

Decreased by £4.07M (-29%)

Employees

66

Increased by 6 (+10%)

Debt Ratio

32%

Increased by 8 (+33%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Castangia, RobertoDirectorItalianEngland471 Jan 2019Active
Cowen, Andrew EdwardDirectorBritishEngland685 Feb 2009Active

Shareholders

Shareholders (1)

Pe487 Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Pe487 Ltd

United Kingdom

Active
Notified 3 Jan 2025
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors,right To Appoint And Remove Directors As Trust

Kolker Capital Inc.

Ceased 15 Jan 2020

Ceased

Group Structure

Group Structure

PE487 LIMITED united kingdom
BIOPHARMA PROCESS SYSTEMS LIMITED Current Company

Charges

Charges

5 outstanding 1 satisfied

Properties

Properties

3 leasehold 3 total
AddressTenurePrice PaidDate Added
6 Winnall Valley Road, Winchester (SO23 0LD) WINCHESTER
Leasehold£285,00020 Jan 2022
premises at Winnall Valley Road, Winchester, (SO23 0LR) WINCHESTER
Leasehold£315,00011 Jun 2019
Biopharma House, Winnall Valley Road, Winchester (SO23 0LD) WINCHESTER
Leasehold-13 May 2008
6 Winnall Valley Road, Winchester (SO23 0LD)
Leasehold £285,000
Added 20 Jan 2022
District WINCHESTER
premises at Winnall Valley Road, Winchester, (SO23 0LR)
Leasehold £315,000
Added 11 Jun 2019
District WINCHESTER
Biopharma House, Winnall Valley Road, Winchester (SO23 0LD)
Leasehold
Added 13 May 2008
District WINCHESTER

Documents

Company Filings

DateCategoryDescriptionDocument
29 Mar 2026Confirmation StatementConfirmation statement made on 17 Mar 2026 with no updates
27 Feb 2026OfficersChange to director Mr Rupert James Graham Lowe on 27 Feb 2026
16 Jan 2026OfficersAppointment of Mr Mattia Cassanelli as director on 1 Dec 2025
16 Jan 2026OfficersAppointment of Mr Andrew John Howells as director on 1 Dec 2025
16 Jan 2026OfficersAppointment of Mr Richard Lewis as director on 1 Dec 2025
29 Mar 2026 Confirmation Statement

Confirmation statement made on 17 Mar 2026 with no updates

27 Feb 2026 Officers

Change to director Mr Rupert James Graham Lowe on 27 Feb 2026

16 Jan 2026 Officers

Appointment of Mr Mattia Cassanelli as director on 1 Dec 2025

16 Jan 2026 Officers

Appointment of Mr Andrew John Howells as director on 1 Dec 2025

16 Jan 2026 Officers

Appointment of Mr Richard Lewis as director on 1 Dec 2025

Recent Activity

Latest Activity

Confirmation statement made on 17 Mar 2026 with no updates

1 months ago on 29 Mar 2026

Change to director Mr Rupert James Graham Lowe on 27 Feb 2026

2 months ago on 27 Feb 2026

Appointment of Mr Mattia Cassanelli as director on 1 Dec 2025

3 months ago on 16 Jan 2026

Appointment of Mr Andrew John Howells as director on 1 Dec 2025

3 months ago on 16 Jan 2026

Appointment of Mr Richard Lewis as director on 1 Dec 2025

3 months ago on 16 Jan 2026